The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
KPV is a synthetic tripeptide consisting of lysine–proline–valine, derived from the C-terminal region of α-melanocyte–stimulating hormone (α-MSH). It is widely examined in vitro for its effects on inflammatory-signaling pathways, immune-modulation mechanisms, and interactions with melanocortin receptors. KPV is also studied in models investigating cytokine-regulation dynamics and epithelial-cell responses.
Image 1 of 1